A Cost-Utility Analysis of Ranibizumab in Age-Related Macular Degeneration Based on Real-Life Observational Data in France
Abstract
Authors
G. de Pouvourville A. Lafuma K. Moeremans E. Nivelle D. Umuhire L. Gerlier F. Maurel A. Ponthieux